Features
Surgical Techniques for Retinal Gene Therapy Delivery
Subretinal injection prevails; other methods are being explored.
By Kenneth C. Fan, MD, MBA
Gene Therapy for Inherited and Rare Retinal Disease
The number of clinical trials is growing.
By Alex Yuan, MD, PhD
Suprachoroidal Gene Transfer
A noninvasive approach to transduce photoreceptors and retinal pigment epithelium.
By Peter A. Campochiaro, MD
Gene Therapy for Neovascular AMD
An update on ongoing clinical trials.
By Fawwaz Siddiqui, BS, Aamir A. Aziz, BS, Arshad M. Khanani, MD, MA, FASRS
Vector Considerations for Ocular Gene Therapy
Adeno-associated virus vectors offer a safe and effective tool for gene delivery.
By Szilárd Kiss, MD
Departments
UPFRONT: A Focus on Gene Therapy
By Peter K. Kaiser, MD
GUEST EDITORIAL: Innovations in Ocular Gene Therapy
GUEST EDITORS, RETINAL PHYSICIAN SPECIAL ISSUE ON GENE THERAPY
By Peter A. Campochiaro, MD, Arshad M. Khanani, MD, MA, FASRS, Rishi P. Singh, MD
SPONSOR LETTER: Gene Therapy for Rare and Chronic Diseases
It's time for industry pioneers to think boldly and broadly.
By Kenneth T. Mills, President and CEO, Regenxbio
FUTURE FILE: Highlighting innovative early-stage and preclinical concepts in retina
By Jerry Helzner, contributing editor
CODING Q&A: EO Codes at Last Get a Revamp
New codes are differentiated by anatomy.
By Suzanne L. Corcoran, COE
CONTROVERSIES IN CARE: Initiating Anti-VEGF in Patients With DME and Good Vision
Protocol V data could inform timing of treatment.
By Michael Colucciello, MD, David S. Boyer, MD, Pravin U. Dugel, MD
RETINA CONVERSATIONS: A Historical Perspective on Gene Therapy for Retinal Disease
A discussion with Mark Pennesi, MD, PhD.
By Jerry Helzner, contributing editor
CLINICAL TRIAL DOWNLOAD: Phase 2b Data for a C5 Inhibitor
Encouraging data support the complement system as a target for geographic atrophy.
By Pravin U. Dugel, MD
NEW PRODUCT APPLICATIONS: Bringing Automation to Fluorescein Angiography Systems
As a true-color sensor, this confocal scanner is the only one of its kind.
By Karen Appold, contributing writer
News
SUBSPECIALTY NEWS: Stem-cell therapy for geographic atrophy, artifacts in OCTA, European opinion for Beovu, and more.
By Jerry Helzner, contributing editor